Back to User profile » Dr Alberto de la Hoz
Papers published by Dr Alberto de la Hoz:
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
![Plain language summary](assets/img/article_icons/plain-language.png)
A Pooled Analysis of Mortality in Patients with COPD Receiving Dual Bronchodilation with and without Additional Inhaled Corticosteroid
![](cr_data/cache/article_graphical_abstract/s350167/graphical_abstract.jpg)
Miravitlles M, Verhamme K, Calverley PMA, Dreher M, Bayer V, Gardev A, de la Hoz A, Wedzicha J, Price D
International Journal of Chronic Obstructive Pulmonary Disease 2022, 17:545-558
Published Date: 11 March 2022
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
![Plain language summary](assets/img/article_icons/plain-language.png)
TRONARTO: A Randomized, Placebo-Controlled Study of Tiotropium/Olodaterol Delivered via Soft Mist Inhaler in COPD Patients Stratified by Peak Inspiratory Flow
![](cr_data/cache/article_graphical_abstract/s324467/graphical_abstract.jpg)
Mahler DA, Ludwig-Sengpiel A, Ferguson GT, de la Hoz A, Ritz J, Shaikh A, Watz H
International Journal of Chronic Obstructive Pulmonary Disease 2021, 16:2455-2465
Published Date: 28 August 2021
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
![Plain language summary](assets/img/article_icons/plain-language.png)
![Thematic Series](assets/img/article_icons/thematic-series.png)
Absence of Adverse Effects of Tiotropium/Olodaterol Compared with the Monocomponents on Long-Term Heart Rate and Blood Pressure in Patients with Moderate-to-Very-Severe COPD
Andreas S, McGarvey L, Bothner U, Trampisch M, de la Hoz A, Fležar M, Buhl R, Alter P
International Journal of Chronic Obstructive Pulmonary Disease 2020, 15:1935-1944
Published Date: 10 August 2020
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
![Plain language summary](assets/img/article_icons/plain-language.png)
![Thematic Series](assets/img/article_icons/thematic-series.png)
No Influence on Cardiac Arrhythmia or Heart Rate from Long-Term Treatment with Tiotropium/Olodaterol versus Monocomponents by Holter ECG Analysis in Patients with Moderate-to-Very-Severe COPD
Andreas S, Bothner U, de la Hoz A, Kloer I, Trampisch M, Alter P
International Journal of Chronic Obstructive Pulmonary Disease 2020, 15:1945-1953
Published Date: 10 August 2020
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
![Plain language summary](assets/img/article_icons/plain-language.png)
![Thematic Series](assets/img/article_icons/thematic-series.png)
A Post Hoc Holter ECG Analysis of Olodaterol and Formoterol in Moderate-to-Very-Severe COPD
Andreas S, Bothner U, de la Hoz A, Kloer I, Trampisch M, Alter P
International Journal of Chronic Obstructive Pulmonary Disease 2020, 15:1955-1965
Published Date: 10 August 2020
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Tiotropium/olodaterol versus tiotropium in Japanese patients with COPD: results from the DYNAGITO study [Corrigendum]
Ichinose M, Nishimura M, Akimoto M, Kurotori Y, Zhao Y, de la Hoz A, Mishima M
International Journal of Chronic Obstructive Pulmonary Disease 2018, 13:3587-3588
Published Date: 30 October 2018
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Tiotropium/olodaterol versus tiotropium in Japanese patients with COPD: results from the DYNAGITO study
Ichinose M, Nishimura M, Akimoto M, Kurotori Y, Zhao Y, de la Hoz A, Mishima M
International Journal of Chronic Obstructive Pulmonary Disease 2018, 13:2147-2156
Published Date: 13 July 2018